New schizophrenia drug shows promise in early trial
NCT ID NCT07467993
First seen Mar 31, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study tests whether a new drug called GXV813 can safely reduce symptoms of schizophrenia during an acute episode. About 142 hospitalized adults aged 18-65 will receive either GXV813 or a placebo. The main goal is to see if the drug improves scores on a standard symptom scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Arch Clinical Trials LLC
RECRUITINGSt Louis, Missouri, 63141, United States
Contact
-
CNRI Los Angeles LLC
RECRUITINGPico Rivera, California, 90660, United States
Contact
-
CenExel iResearch
RECRUITINGDecatur, Georgia, 30030, United States
Contact
-
Pillar Clinical Research LLC
RECRUITINGBentonville, Arkansas, 72712, United States
Contact
-
Pillar Clinical Research LLC
RECRUITINGChicago, Illinois, 60641, United States
Contact
-
Segal Institute for Clinical Research
RECRUITINGMiami, Florida, 33016, United States
Contact
-
Uptown Research Institute LLC
RECRUITINGChicago, Illinois, 60640, United States
Contact
Conditions
Explore the condition pages connected to this study.